BCR and B-cell chronic lymphocytic leukemia: This result is surprising in light of our previous work showing Lck expression level is important for BCR signalling strength22, and implies that although Lck, like other kinases within the BCR signalling pathway, is targetable in CLL, measurement of its expression levels between patient samples is unlikely to be useful for stratifying BCR-targeted therapies.